Broader use for Schering allergy during
In a move that could reduce generic competition for Schering-Plough Corp's stable of allergy treatments, a federal advisory panel has recommended that the nonprescription drug Claritin be approved
In a move that could reduce generic competition for Schering-Plough Corp's stable of allergy treatments, a federal advisory panel has recommended that the nonprescription drug Claritin be approved